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Human fibroblast Gene expression 
Modulation Using 940 NM Diode 
Laser
Rebeca illescas-Montes1,2, Lucía Melguizo-Rodríguez1,2, Olga García-Martínez1,2,  
elvira de Luna-Bertos1,2, Francisco Javier Manzano-Moreno2,3, Concepción Ruiz1,2,4 & 
Javier Ramos-torrecillas1,2
Low-Level Laser Therapy is used as regenerative therapy in different clinical fields. This is due to its 
photobiomodulation effect via cell signaling on different cell populations, Including fibroblasts, cells 
involved in tissue regeneration and healing. The aim was to analyze the effect of 940 nm diode laser on 
the gene expression of different markers involved in fibroblast growth, differentiation, and migration. 
Real-time polymerase chain reaction (q-RT-PCR) was used to quantify the expression of fibroblast 
growth factor (FGF), connective tissue growth factor (CTGF), vascular-endothelial growth factor 
(VEGF), transforming growth factor β1 (TGF-β1), TGFβ-receptors (tGfβR1, TGFβR2, and TGFβR3), 
discoidin-domain receptor-2 (DDR2), matrix metalloproteinase-2 (MMP2), α-actin, fibronectin, decorin, 
and elastin on human fibroblast, treated with single dose (T1) or two doses (T2) of diode laser at 0.5 
Watts and 4 J/cm2. A significant increase in the expression of FGF, TGF-β1, TGFβR1, TGFβR2, α-actin, 
fibronectin, decorin, DDR2 and MMP2 was observed after both treatments. A decrease was observed 
in expression of elastin (T1 and T2), and CTGF (T2). These changes underlie the biostimulatory effect 
of laser on fibroblasts, which translates into an increase in short-term proliferation and in long-term 
differentiation to myofibroblasts. These data support the therapeutic potential of diode laser for wound 
repair.
Fibroblasts are responsible for forming and maintaining soft connective tissue and constitute the main source 
of collagen for the extracellular matrix (ECM). Fibroblasts are in a quiescent state in healthy conjunctive tissue, 
being metabolically active but unable to proliferate, although they slowly synthetize, degrade, and organize the 
ECM to maintain the tissue structure1,2. However, tissue injuries induce major changes in cell signaling that trans-
late into cell activation, stimulating the formation of granulation tissue with a high cell component (fibroblasts, 
macrophages, myofibroblasts, neovasculature) and thereby contributing to the creation of new mature connective 
tissue, favoring tissue regeneration1. Highly active ECM formation/synthesis by fibroblasts exceeds degradation 
in this phase3. However, processes of connective tissue re-epithelialization, healing, and angiogenesis can be com-
promised in cases of chronic injury4.
Low-Level Laser Therapy (LLLT) is applied in multiple clinical fields5. It is based on the application of 
low-power amplified light radiation capable of promoting biochemical, bioelectric, and structural changes that 
produce analgesic, anti-inflammatory, and/or microcirculation-stimulating effects6–8. Its usefulness in the treat-
ment of chronic wounds is currently under debate8,9.
The photobiomodulation effect of lasers depend on their type and the emission wavelength and energy 
selected8. The 940 nm diode laser has biostimulatory effect on various cell populations involved in regenerative 
processes, including osteoblasts in hard tissues10–12 and fibroblasts in soft tissues13. Treatment with this laser for 24 
or 72 h increased the proliferative capacity of cultured human fibroblasts as a function of the energy dose applied 
and induced their expression of α-actin, a marker of fibroblast differentiation13.
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The objective of this study was to determine the effects on fibroblasts of treatment with 940 nm diode laser, 
analyzing the expression of fibroblast growth and differentiation markers and exploring the usefulness of LLLT 
in soft connective tissue healing.
Results
The gene expression of growth factors is depicted in Fig. 1, whereas the gene expression of differentiation markers 
and extracellular matrix elements is showed in Fig. 2.
Effect of diode laser on the expression of FGF, CTGF, VEGF, TGF-β1, and TGF-β1 receptors genes. 
Quantitative RT-PCR (q-RT-PCR) analysis was used to evaluate the expression of the fibroblast markers assayed. 
As depicted in Fig. 1, cells receiving a single dose (T1) showed increased gene expression of FGF, TGF-β1, 
TGFβR1, and TGFβR2, while cells receiving two doses (T2) showed increased expression of all markers except for 
TGFβR3, which did not change, and CTGF, whose expression was significantly reduced with respect to controls.
Effect of diode laser on the expression of α-actin, fibronectin, decorin, elastin, DDR2, and 
MMP2. Figure 2 displays the quantification of α-actin, fibronectin, decorin, elastin, DDR2, and MMP2 gene 
expression by q-RT-PCR. As observed, the expression of α-actin, fibronectin, decorin, DDR2 and MMP-2 was 
increased versus controls with both treatments (T1 and T2), whereas the expression of elastin was reduced with 
T1 and T2 treatments.
The Table 1 shows the gene expression of the different markers studied and the difference between the T1 and 
T2 group.
Discussion
Treatment with 940 nm diode laser exerts a photobiomodulation effect on fibroblasts under specific application 
(energy dose/transmission mode) conditions13. The present study demonstrates that in vitro treatment with this 
laser modulates the expression of the human fibroblast markers FGF, CTGF, VEGF, TGF-β1, TGFβR1, TGFβR2, 
TGFβR3, α-actin, fibronectin, decorin, elastin, DDR2, and MMP2, although the effect depended on the treatment 
protocol. The proteins encoding these markers play a major role in wound healing by stimulating fibroblast pro-
liferation, migration, and/or maturation3,14,15.
Figure 1. Expression of fibroblasts genes (FGF, CTGF, VEGF, TGF-β1, TGFβR1, TGFβR2, and TGFβR3) 
treated with a 940 nm diode laser at 0.5 Watts and 4 J/cm2, following two treatment protocols: one dose (T1) 
and two doses (T2). Data are expressed as ng of mRNA per average ng of housekeeping mRNAs ± SD. *p ≤ 0.05 
Significance in the treated group was determined with respect to the control group.
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FGF promotes fibroblast mitogenesis, favoring the formation of granulation tissue and promoting 
re-epithelization and damaged tissue remodeling16. Both of our treatments with 940 nm diode laser (single dose 
or two doses) significantly increased FGF expression, although the effect was lower with two doses. Previous stud-
ies reported a significance increase in the growth rate of human fibroblasts at 24 h after a single treatment with 
this laser under the same energy conditions (0.5 W, 4/Jcm2) but not at 72 h13. Khoo et al.17 observed a significant 
increase in FGF expression in fibroblasts from diabetic rats irradiated with diode laser at a single energy dose 
(810 nm, 10 mW, 1 J/cm2). Likewise, Damante et al.18 also recorded an increase in the FGF expression of cultured 
gingival fibroblasts treated with infrared laser at different energy densities (780 nm, 40 mW, 3 J/cm2, and 5 J/cm2).
TGF-β1 is a growth factor with multiple functions, including stimulation of fibroblast proliferation, migra-
tion, and adhesion and promotion of the production of ECM elements19. TGF-β1 also favors the maturation of 
fibroblasts, inducing their differentiation to myofibroblasts, which are responsible for contraction and for syn-
thetizing ECM elements20. Nonetheless, TGF-β1 overexpression has been considered as largely responsible for 
hypertrophic scars and keloids because of its stimulation of CTGF secretion21. In the present study, both laser 
treatments (single dose and two doses) significantly increased expression by the fibroblasts of TGF-β1 and its 
receptors TGFβR1 and TGFβR2. The increase in TGF-β1 expression was lower after two doses than after one, 
which may be explained by the maturation process of the fibroblasts, given that TGF-β1 expression induced by 
the single dose may be related to a fibroblastic cell phenotype, while the presence of differentiated myofibroblasts 
would have reduced this expression at 72 h after the second dose. CTGF expression was not changed by the 
single-dose treatment but was significantly decreased by the two-dose treatment.
The proteoglycan decorin has key functions in the ECM, inactivating TGF-β and CTGF. For this reason, 
decorin levels are lower and elastin fiber deposits higher in hypertrophic scars than in normal skin22,23. Both laser 
treatments produced a significant increase versus controls in the fibroblast expression of decorin that was higher 
in the fibroblasts receiving two doses, which would be related to the expression pattern of TGF-β and CTGF. The 
two treatments also produced a significant reduction in elastin expression. These results may contribute to explain 
the favorable effect of laser on soft tissue regeneration without the potential risk of wound-healing defects such as 
hypertrophic scars or keloids, among others, although in vivo studies are warranted to assess the optimal calibra-
tion of laser-induced activation to ensure normal scar formation.
Angiogenesis is a complex and decisive physiological process in wound-healing and tissue regeneration24, and 
it depends on VEGF, among other growth factors, and on ECM elements. We achieved a significant increase in 
VEGF expression with the two-dose treatment, in line with various studies of laser treatments in vivo (wound 
models in rats: 660 nm, 16 mW, 10 J/cm2; 660 nm, 30 mW 72 J/cm2) and in vitro (cultured human fibroblasts: 
660 nm, 35 mW, 1–5 J/cm2)25–27. This rise in VEGF expression would contribute to tissue regeneration.
DDR2 collagen receptors regulate fibroblast proliferation and migration and ECM synthesis, which are crucial 
in wound-healing. There is also a close relationship between DDR2 and MMP-2, predominant proteases in the 
ECM that are responsible for wound remodeling. Thus, a decrease in DDR2 was reported to reduce migration 
and MMP-2 expression in fibroblasts28. In the present study, treatment with 940 nm diode laser increased the 
expression of DDR-2 and MMP-2 in human fibroblasts, consistent with observations29 of a significant increase 
in MMP-2 expression by human fibroblasts treated with other types of laser (erbium: YAG laser, 5 or 10 J/cm2).
Figure 2. Expression of fibroblasts genes (α-actin, fibronectin, decorin, elastin, DDR2, and MMP2) treated 
with a 940 nm diode laser at 0.5 Watts and 4 J/cm2, following two treatment protocols: one dose (T1) and 
two doses (T2). Data are expressed as ng of mRNA per average ng of housekeeping mRNAs ± SD. *p ≤ 0.05 
Significance in the treated group was determined with respect to the control group.
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Gen Treatment Mean Standard Deviation p value
FGF
Control 601.45 68.44
T1 1924.05 349.99 0.05*
T2 1046.69 117.88 0.05*
T1 Vs T2 0.513
CTGF
Control 710.4 582.65
T1 909.96 483.99 0.497
T2 167.73 130.26 0.042*
T1 Vs T2 0.043*
VEGF
Control 41.9 0.73
T1 41.25 1.46 0.658
T2 53.55 6.1 0.05*
T1 Vs T2 0.05*
TGF-β1
Control 40272.68 1564.55
T1 77088.78 3480.91 0.05*
T2 54227.56 3255.26 0.05*
T1 Vs T2 0.275
TGFβR1
Control 44943.09 800.95
T1 59638.95 5223.23 0.05*
T2 65203.3 610.3 0.05*
T1 Vs T2 0.268
TGFβR2
Control 85792.51 3856.83
T1 119296.52 7411.73 0.002*
T2 174964.17 2677.26 0.000*
T1 Vs T2 0.05*
TGFβR3
Control 102466.73 55209.72
T1 86085.74 9883.43 0.497
T2 116559.82 19233.12 0.661
T1 Vs T2 0.014*
α-actin
Control 1.23 0.35
T1 3.5 0.37 0.034*
T2 4.84 1.11 0.021*
T1 Vs T2 0.034*
fibronectin
Control 1649.99 428.63
T1 11576.43 276.38 0.05*
T2 4893.05 529.88 0.05*
T1 Vs T2 0.05*
decorin
Control 514.9 67.89
T1 702.46 62.83 0.05*
T2 976.28 59.02 0.05*
T1 Vs T2 0.001*
elastin
Control 488.14 37.52
T1 419.71 22.39 0.05*
T2 140.3 17.04 0.05*
T1 Vs T2 0.05*
DDR2
Control 48.39 2.87
T1 53.81 3.49 0.05*
T2 59.72 4.02 0.05*
T1 Vs T2 0.05*
MMP2
Control 1270.19 99.45
T1 1691.09 152.54 0.034*
T2 2002.29 233.74 0.034*
T1 Vs T2 0.05*
Table 1. Gene expression of fibroblasts treated with a 940 nm diode laser at 0.5 Watts and 4 J/cm2, following two 
treatment protocols: one dose (T1) and two doses (T2). FGF, fibroblast growth factor; CTGF, connective tissue 
growth factor; VEGF, vascular endothelial growth factor; TGF-β1, transforming growth factor β1; TGFβR1, 
transforming growth factor β-receptor 1; TGFβR2, transforming growth factor β-receptor 2; TGFβR3, transforming 
growth factor β-receptor 3; DDR2, discoidin domain receptor 2; MMP2, matrix metalloproteinase-2. Data are 
expressed as mean of ng of mRNA per average ng of housekeeping mRNAs and Standard Deviation. *p ≤ 0.05.
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Myofibroblasts are present in granulation tissue and possess intermediate characteristics between fibroblasts 
and smooth muscle cells. They play a major role in the inflammation, repair, and remodeling of different tissues. 
Myofibroblasts are differentiated from fibroblasts and are characterized by the expression of α-actin30,31. Both 
laser treatments of our cultured human fibroblasts produced a significant increase in the expression of the myofi-
broblast markers α-actin and fibronectin30. These results agree with the confocal microscopy observations of 
intense fibronectin and α-actin expressions after the treatment of fibroblasts treated with laser (940 nm, 0.5 W, 3 
or 4 J/cm2)13. The long-term increase in α-actin gene expression is also associated with higher TGF-β1 expression, 
which is proposed as a triggering factor for the differentiation from fibroblast to myofibroblast20. The results of 
our study suggest that laser treatment increases the growth and migration of fibroblasts and induces their differ-
entiation, thereby favoring tissue wound healing, seeming the T2 treatment to be a better option in tissue regen-
eration. However, there have been calls for novel approaches to chronic wounds, including the utilization of laser 
or platelet-rich plasma32,33. These therapies could complement conventional moist wound healing treatments with 
the aim of reducing the healing time and improving the patient’s quality of life.
In conclusion, the biostimulatory effects of 940 nm diode laser on fibroblasts observed in this study suggest its 
high therapeutic potential for wound regeneration. However, further animal and human studies are warranted to 
verify its clinical usefulness.
Methods
Cell cultures. The human CCD-1064Sk epithelial fibroblast cell line was purchased from American Type 
Cultures Collection (ATCC, Manassas, VA, USA) (ATCC: CRL-2076) and maintained in Dulbecco’s Modified 
Eagle Medium (DMEM; Invitrogen Gibco Cell Culture Products, Carlsbad, CA) with 100 IU/mL penicillin (Lab 
Roger SA, Barcelona, Spain), 50 μg/mL gentamicin (Braum Medical SA, Jaen, Spain), 2.5 μg/mL amphotericin 
B (Sigma -Aldrich Co. Chem. Comp., St. Louis, Mo, USA), 1% glutamine (Sigma -Aldrich Co), and 2% HEPES 
(Sigma -Aldrich Co) supplemented with 10% fetal bovine serum (FBS) (Gibco, Paisley, UK). Cultures were kept at 
37 °C in humidified atmosphere of 95% air and 5% CO2. Cells were detached from the culture flask with a solution 
of 0.05% trypsin (Sigma -Aldrich Co) and 0.02% ethylene diamine tetra-acetic acid (EDTA) (Sigma -Aldrich Co) 
and were then washed and suspended in complete culture medium with 10% FBS.
Laser irradiation. This study used a diode laser, equipped with a biostimulation hand piece, that operates 
at a wavelength of 940 nm with maximum power output of 10 W and spot diameter of 400 microns (Biolase 
Technology, Inc., Irvine, CA).
Cells were seeded at 2 × 104 cells/ml in 24-well plates with an adequate between-well distance to avoid irradi-
ation from proximal wells and scattered irradiation. Cells were then laser-irradiated in uncovered plates at room 
temperature with 0.5 W power and 4 J/cm2 energy density in continuous wave (CW), previously found to be 
optimal for biostimulatory effect on this cell population13, following two treatment guidelines: T1) single energy 
dose (0 h) and quantitative analysis after 144 h of treatment; T2) two energy doses, one at baseline (0 h) and the 
other at 72 h, analyzing cells at 72 h after the second dose (144 h after the first dose). A control group of untreated 
cells was included in all experiments. Before treatments, cells were starved for synchronization by growing them 
in DMEM without FBS. The irradiation time was determined according to the energy density and power applied 
as 12.32 seconds.
RNA extraction and cDNA synthesis (reverse transcription). The method described by 
Manzano-Moreno et al.34 was used to extract the mRNA of cells undergoing T1 or T2 treatment and of control 
cells cultured under the same conditions. All assays were run in triplicate. Subsequently, an equal amount of RNA 
(1 μg total RNA in 40 μL total volume) was reverse-transcribed to cDNA and amplified by PCR using the iScript™ 
cDNA Synthesis Kit (Bio-Rad laboratories, Hercules, CA) in accordance with the manufacturer’s instructions.
Gene Sense Primer Antisense Primer
Amplicon 
(bp)
FGF 5′-CCCATATTCCCTGCACTTTG-3′ 5′-ACCTTGACCTCTCAGCCTCA-3′ 195
CTGF 5′-CCTGGTCCAGACCACAGAGT-3′ 5′-TGGAGATTTTGGGAGTACGG-3′ 194
VEGF 5′-CCTTGCTGCTCTACCTCCAC-3′ 5′-CACACAGGATGGCTTGAAGA-3′ 197
TGF-β1 5′-TGAACCGGCCTTTCCTGCTTCTCATG-3′ 5′-GCGGAAGTCAATGTACAGCTGCCGC-3′ 152
TGFβR1 5′-ACTGGCAGCTGTCATTGCTGGACCAG-3′ 5′-CTGAGCCAGAACCTGACGTTGTCATATCA-3′ 201
TGFβR2 5′-GGCTCAACCACCAGGGCATCCAGATGCT-3′ 5′-CTCCCCGAGAGCCTGTCCAGATGCT-3′ 139
TGFβR3 5′-ACCGTGATGGGCATTGCGTTTCCA-3′ 5′-GTGCTCTGCGTGCTGCCGATGCTGT-3′ 173
DDR2 5′-GAACCCAAACATCATCCATC-3′ 5′-CTTCATGCCAGAGGCAATTT-3′ 199
MMP2 5′-CCAAGAACTTCCGTCTGTCC-3′ 5′-TGAACCGGTCCTTGAAGAAG-3′ 195
α-actin 5′-TCCTGCTCCTCTCTGTCTCAT-3′ 5′-AGTCAGAGCTTTGGCTAGGAA-3′ 96
fibronectin 5′-GCCATGACAATGGTGTGAAC-3′ 5′-GCAAATGGCACCGAGATATT-3′ 200
decorin 5′-GGGCTGGCAGAGCATAAGTA-3′ 5′-CAGAGCGCACGTAGACACAT-3′ 196
elastin 5′-GGTGTAGGTGGAGCTTTTGC-3′ 5′-CTGTTGGGTAACCAGCCTTG-3′ 199
Table 2. Primer sequences for the amplification of cDNA by real-time PCR.
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Real-time polymerase chain reaction (q-RT-PCR). The mRNA of fibroblast growth factor (FGF), con-
nective tissue growth factor (CTGF), vascular endothelial growth factor (VEGF), transforming growth factor β1 
(TGF-β1), transforming growth factorβ-receptors (TGFβR1, TGFβR2 and TGFβR3), discoidin domain receptor 2 
(DDR2), matrix metalloproteinase-2 (MMP2), α-actin, fibronectin, decorin, and elastin was detected with prim-
ers designed using the NCBI-nucleotide library and Primer3-design (Table 2). All primers had been matched to 
the mRNA sequences of the target genes (NCBI Blast software). Final results were normalized using ubiquitin C 
(UBC), peptidylprolyl isomerase A (PPIA), and ribosomal protein S13 (RPS13) as stable housekeeping genes35.
Quantitative RT-PCR (q-RT-PCR) was performed using the SsoFast™ EvaGreen® Supermix Kit (Bio-Rad 
laboratories) in accordance with the manufacturer’s protocol. The comparative Ct method was used for the rela-
tive quantification of gene expression. The mRNA concentration for each gene was expressed in ng of mRNA per 
average ng of housekeeping mRNAs. cDNA of cells from at least three independent cultures were analyzed using 
qRT-PCR.
Statistical analysis. R software (R Foundation for Statistical Computing, Vienna, Austria) was used for the 
statistical analysis. Differences between means were evaluated by Mann-Whitney U test. Data are reported as 
means ± standard deviation (SD). Differences between experimental groups were considered statistically signif-
icant at p ≤ 0.05.
Data Availability
Datasets generated during and/or analyzed during the current study are available from the corresponding author 
upon reasonable request.
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